Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

71.28
+0.08000.11%
Volume:8.99M
Turnover:640.10M
Market Cap:105.67B
PE:36.74
High:71.94
Open:70.73
Low:70.12
Close:71.20
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.77
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.36
PE(LYR):36.74

Loading ...

Company Profile

Company Name:
Boston Scientific
Exchange:
NYSE
Establishment Date:
1979
Employees:
59000
Office Location:
300 Boston Scientific Way,Marlborough,Massachusetts,United States
Zip Code:
01752-1234
Fax:
- -
Introduction:
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Directors

Name
Position
David C. Habiger
Vice Chairman of the Board and Independent Director
Michael F. Mahoney
Chairman of the Board and Chief Executive Officer and Director and President
Catherine R. Smith
Independent Director
Cheryl B. Pegus
Independent Director
Christophe P. Weber
Independent Director
David S. Wichmann
Independent Director
Edward J. Ludwig
Lead Independent Director
Ellen M. Zane
Independent Director
Jessica L. Mega
Independent Director
Susan E. Morano
Independent Director

Shareholders

Name
Position
Michael F. Mahoney
Chairman of the Board and Chief Executive Officer and Director and President
Jonathan Monson
Chief Financial Officer and Executive Vice President
Miriam O Sullivan
Chief Human Resources Officer and Senior Vice President
Arthur C. Butcher
Executive Vice President and Group President
Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiovascular
Padraig A. O Connor
Executive Vice President, Global Operations
Vance R. Brown
Corporate Secretary and Executive Vice President and General Counsel